SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5B217EA6A3F14FED1C8BB465A0569E76C87FDB6EB854D436E91010A584C944CCC1A9DEB228ADF182400ED069FC9B6681>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5B217EA6A3F14FED1C8BB465A0569E76C87FDB6EB854D436E91010A584C944CCC1A9DEB228ADF182400ED069FC9B6681
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5B217EA6A3F14FED1C8BB465A0569E76C87FDB6EB854D436E91010A584C944CCC1A9DEB228ADF182400ED069FC9B6681
http://www.w3.org/2000/01/rdf-schema#comment
"studies describe 2 novel modes of action of ticagrelor inhibition of platelet ENT1 and inverse agonism at the P2Y12R that contribute to its effective inhibition of platelet activation."
xsd:string
http://purl.uniprot.org/uniprot/#_284FEA017FE3E814B49CFF462E9473DBFF2F6109C15AF0B814C86F3B26D0BE319EE7197D7CE8ABC1FD9419E8B048E8F6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5B217EA6A3F14FED1C8BB465A0569E76C87FDB6EB854D436E91010A584C944CCC1A9DEB228ADF182400ED069FC9B6681
http://purl.uniprot.org/uniprot/A8K7T1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5B217EA6A3F14FED1C8BB465A0569E76C87FDB6EB854D436E91010A584C944CCC1A9DEB228ADF182400ED069FC9B6681
http://purl.uniprot.org/uniprot/#_A8K7T1-mappedCitation-27694321
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5B217EA6A3F14FED1C8BB465A0569E76C87FDB6EB854D436E91010A584C944CCC1A9DEB228ADF182400ED069FC9B6681